Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma

Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma

Glaucoma is a neurodegenerative disease that causes blindness. In this study, we aimed to evaluate the protective role of cilastatin (CIL), generally used in the treatment of nephropathologies associated with inflammation, in an experimental mouse model based on unilateral (left) laser-induced ocula...

Full description

Bibliographic Details
Main Authors: Miguel A. Martínez-López, Sara Rubio-Casado, Diego San Felipe, Beatriz Martín-Sánchez, José A. Fernández-Albarral, Elena Salobrar-García, José A. Matamoros, José M. Ramírez, Rosa de Hoz, Juan J. Salazar, Eva M. Marco, Ana I. Ramírez, Alberto Lázaro, Meritxell López-Gallardo
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
retina
glaucoma
ocular hypertension (OHT)
retinal ganglion cells (RGCs)
macroglial cells
microglial cells
Online Access:https://www.mdpi.com/1422-0067/25/6/3115

Internet

https://www.mdpi.com/1422-0067/25/6/3115

Similar Items